Artur C. Fassoni, Christoph Baldow, Ingo Roeder and Ingmar Glauche (2018) “Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data”, Haematologica. Pavia, Italy, 103(11), pp. 1825-1834. doi: 10.3324/haematol.2018.194522.